DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-16.67%
US · US
EPAM.US latest organized financial period shows revenue lacks a complete YoY comparison and net income declined -16.91% YoY. Current price is about 112 USD, while the model base case is about 97.12 USD; the current price sits +15.5% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:27
Hover each model row to inspect formulas and inputs.
+15.52%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-16.67%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
+15.52%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -3.8% annualized FCF growth.
Estimates earnings power value without assuming growth.
+37.62%
Updated: 2026/04/29 15:27
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset impairment | Impairment | -138K USD | Medium |
| 2025/12/31 | Restructuring charges | Restructuring | -38M USD | Medium |
| 2024/12/31 | Asset impairment | Impairment | -659K USD | Medium |
| 2024/12/31 | Restructuring charges | Restructuring | -49M USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -14M USD | Medium |
| 2023/12/31 | Business sale gain/loss | Asset sale gain/loss | -61M USD | Medium |
| 2023/12/31 | Restructuring charges | Restructuring | -46M USD | Medium |
| 2022/12/31 | Asset impairment | Impairment | -56M USD | Medium |
| 2021/12/31 | Asset impairment | Impairment | -228K USD | Medium |
| 2025/09/30 | Restructuring charges | Restructuring | -26M USD | Medium |
| 2025/06/30 | Restructuring charges | Restructuring | -17M USD | Medium |
| 2025/03/31 | Restructuring charges | Restructuring | -4M USD | Medium |
| 2024/09/30 | Asset impairment | Impairment | -312K USD | Medium |
| 2024/09/30 | Restructuring charges | Restructuring | -42M USD | Medium |
| 2024/06/30 | Asset impairment | Impairment | -77K USD | Medium |
| 2024/06/30 | Restructuring charges | Restructuring | -26M USD | Medium |
| 2024/03/31 | Asset impairment | Impairment | -36K USD | Medium |
| 2024/03/31 | Restructuring charges | Restructuring | -11M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | - | 378M USD | 416M USD | 613M USD | 6.72 | 7.4 |
| 2024/12/31 | Annual | - | 455M USD | 505M USD | 527M USD | 7.84 | 8.7 |
| 2023/12/31 | Annual | - | 417M USD | 539M USD | 534M USD | 7.06 | 9.12 |
| 2022/12/31 | Annual | - | 419M USD | 475M USD | 382M USD | 7.09 | 8.04 |
| 2021/12/31 | Annual | - | 482M USD | 482M USD | 461M USD | 8.15 | 8.15 |
Profit after costs, expenses, interest, and taxes.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.